Alpha Teknova Stock Quote TKNO - Stock Price, News, Charts, Message Board, Trades

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

5.45

Bid

4.69

Ask

5.69

Volume

109,328

4.815 Day's Range 5.4699

1.155 52 Week Range 5.455

Market Cap

290.501M

Previous Close

4.83

Open

4.87

Last Trade

5.44

Last Trade Time

Financial Volume

$ 565,126

VWAP

5.1691

Average Volume (3m)

455,761

Shares Outstanding

53,302,993

Dividend Yield

PE Ratio

-7.90

Earnings Per Share (EPS)

-0.69

Revenue

36.68M

Net Profit

-36.78M

Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture ... Alpha Teknova Inc provides critical reagents that enable the discovery, development, and production of biopharmaceutical products such as drug therapies, novel vaccines, and molecular diagnostics. Its product offerings include pre-poured media plates for cell growth and cloning, liquid cell culture media and supplements for cellular expansion, and molecular biology reagents for sample manipulation, resuspension, and purification. Show more

Sector

In Vitro,in Vivo Diagnostics

Industry

In Vitro,in Vivo Diagnostics

Website

www.teknova.com

Headquarters

Wilmington, Delaware, USA

Founded

Alpha Teknova Inc is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker TKNO. The last closing price for Alpha Teknova was $4.83. Over the last year, Alpha Teknova shares have traded in a share price range of $ 1.155 to $ 5.455.

Alpha Teknova currently has 53,302,993 shares outstanding. The market capitalization of Alpha Teknova is $257.45 million. Alpha Teknova has a price to earnings ratio (PE ratio) of -7.90.

Form 424B3 - Prospectus [Rule 424(b)(3)]

Form EFFECT - Notice of Effectiveness

Form S-1 - General form for registration of securities under the Securities Act of 1933

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

Teknova Reports Second Quarter 2024 Financial Results

Second quarter 2024 total revenue was $9.6 million, up 3% sequentiallyRaised $15.4 million of equity capital in July 2024Launched two new offerings: Express-TekSM Production and RUO+ manufacturing...

Teknova Introduces Proprietary Express-Tek℠ Production Service and Expanded Manufacturing Grade Options to Expedite Novel Therapy Development

Express-TekSM Production enables customers to have their products enter production in days instead of weeks, significantly shortening turnaround time New manufacturing grade, RUO+, provides a...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0.45	9	5	5.45	4.68	66759	4.91875843	CS
4	0.89	19.5175438596	4.56	5.45	4.15	121231	4.84658907	CS
12	3.5	179.487179487	1.95	5.455	1.9	455761	3.52014737	CS
26	2.99	121.544715447	2.46	5.455	1.155	331574	2.92682649	CS
52	3.29	152.314814815	2.16	5.455	1.155	178425	2.9187374	CS
156	-19.73	-78.3558379666	25.18	27.6	1.155	103042	4.93150419	CS
260	-15.27	-73.6969111969	20.72	30.89	1.155	109505	7.5230527	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
CAMPCAMP4 Therapeutics Corporation	10.75 (2,587.50%)	378.47k
TWGTop Wealth Group Holding Ltd	$ 7.14 (233.64%)	154.23M
NIVFNewGenIvf Group Ltd	$ 0.98 (63.42%)	58.51M
ATIFATIF Holdings Ltd	$ 1.235 (58.33%)	3.85M
VERBVerb Technology Company Inc	$ 7.91 (51.82%)	15.55M
BYUBAIYU Holdings Inc	$ 0.299 (-35.28%)	10.99M
TURBTurbo Energy SA	$ 2.1511 (-29.01%)	2.83M
SMSTDefiance Daily Target 1.5X Short MSTR ETF	$ 7.898 (-23.62%)	984.8k
VEEAVeea Inc	$ 3.27 (-23.24%)	279.91k
INHDInno Holdings Inc	$ 3.74 (-22.41%)	243.8k
JTAIJet AI Inc	$ 0.1009 (23.50%)	335.77M
CDTConduit Pharmaceuticals Inc	$ 0.116 (13.28%)	257.95M
NVDANVIDIA Corporation	$ 134.80 (-0.01%)	161.76M
LUXHLuxUrban Hotels Inc	$ 0.0532 (5.35%)	159.27M
TWGTop Wealth Group Holding Ltd	$ 7.14 (233.64%)	149.99M